Rheumatology Highlights Report

Rheumatology Highlights Report

Do you have 15 minutes? A patient cancelled an
appointment or you finished a meeting early? Give us
15 minutes and we will give you the world of rheumatology.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


The Rheumatology Highlights Report is designed for the busy clinician. It is designed to provide highlights from key scientific presentations and/or abstracts presented at international and national rheumatology meetings. Clinical experts attending these meetings have selected the most significant data to report. Each activity includes a 15-minute presentation with supporting materials and commentary on the clinical implications of the data.

Target Audience

Rheumatologists are the primary audience for these activities, as well as other health care professionals managing patients with rheumatic disease, including primary care practitioners, internists, and cardiologists.

Webcast

Miscellaneous Rheumatic Disorders

Estimated Time: 15 minutes
Release Date: July 20, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 20, 2010
Specialties: Rheumatology / Immunology, Cardiology

Systemic Lupus Erythematosus: Pathology, Diagnosis, and Treatment

Estimated Time: 15 minutes
Release Date: July 20, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 20, 2010
Specialties: Rheumatology / Immunology, Cardiology

Cardiovascular Aspects of Rheumatic Disease

Estimated Time: 15 minutes
Release Date: July 20, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 20, 2010
Specialties: Rheumatology / Immunology, Cardiology

Rheumatoid Arthritis: Non-biologics, Including DMARD Therapy – Advances in Efficacy and Safety

Estimated Time: 15 minutes
Release Date: July 20, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 20, 2010
Specialties: Rheumatology / Immunology, Cardiology

Metabolic Bone Disease

Estimated Time: 15 minutes
Release Date: July 28, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 28, 2010
Specialties: Rheumatology / Immunology, Cardiology

Psoriatic Arthritis

Estimated Time: 15 minutes
Release Date: July 28, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 28, 2010
Specialties: Rheumatology / Immunology, Cardiology

Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures

Estimated Time: 15 minutes
Release Date: August 3, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: August 3, 2010
Specialties: Rheumatology / Immunology, Cardiology

Vasculitis: Pathology, Diagnosis, and Treatment

Estimated Time: 15 minutes
Release Date: August 3, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: August 3, 2010
Specialties: Rheumatology / Immunology, Cardiology

Ankylosing Spondylitis

Estimated Time: 15 minutes
Release Date: August 3, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: August 3, 2010
Specialties: Rheumatology / Immunology, Cardiology

Rheumatoid Arthritis: Biologic DMARD - Safety

Estimated Time: 15 minutes
Release Date: July 28, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 28, 2010
Specialties: Rheumatology / Immunology, Cardiology

Rheumatoid Arthritis: Biologic DMARD - Efficacy

Estimated Time: 15 minutes
Release Date: July 28, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: July 28, 2010
Specialties: Rheumatology / Immunology, Cardiology

Advances in Basic Science

Estimated Time: 15 minutes
Release Date: August 20, 2009
Type: Webcast

Technical Requirements: Windows Media
Expiration Date: August 20, 2010
Specialties: Rheumatology / Immunology, Cardiology

Series Objectives

  1. Summarize results from rheumatic disease research studies and clinical trials and assess their clinical practice impact.
  2. Review presented data on safety and efficacy of biologic use in RA treatment models.
  3. Describe new data on the pathophysiology of cardiovascular disease in patients with rheumatic disease.
  4. Evaluate research on advances in biologics including TNF inhibitors, T cell inhibitors, B cell inhibitors, and new biologic therapies.
  5. Analyze the impact of research on diagnosis and treatment for ankylosing spondylitis, psoriatic arthritis, vasculitis, systemic lupus, and metabolic bone disease.
  6. Discuss salient advances in basic science, including immunologic-oriented genetics, protease research, and pathogenetic research.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman, Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

 

 
Bookmark this Chapter
Copyright © 2000-2009 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195
Copyright © 2000-2009 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195